LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

4th September 2026

Curia Celebrates Expansion of Albuquerque Facility with Ribbon-Cutting Ceremony

2nd September 2026

FibroFind appoints leading transplant physician Professor Andrew Fisher as Chief Medical Officer

2nd September 2026

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

1st September 2026

Bio-Rad Expands Foresight Pro Prepacked Chromatography Columns with Nuvia Ion Exchange and Mixed-Mode Resins for Biomanufacturing

1st September 2026

CPHI Milan Pharma Awards 2026 Finalists Announced

1st September 2026

Styx Biotechnologies Announces Strategic Agreement with ZoeNCure Therapeutics to Accelerate Next-Generation ADC Pipeline to Clinic

31st August 2026

Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases

31st August 2026

HAS Group announces successful Swissmedic inspection of the new ADC Suite at Cerbios-Pharma SA

28th August 2026

Neuland Laboratories expands Sterile API Manufacturing capacity

27th August 2026

CPHI Pharma Awards finalists announced across innovation, sustainability and leadership categories

27th August 2026

Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations